Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Krens SD, Lassche G, Jansman FGA, Desar IME, Lankheet NAG, Burger DM, van Herpen CML, van Erp NP.
Lancet Oncol. 2019 Apr;20(4):e200-e207. doi: 10.1016/S1470-2045(19)30145-7.
Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Renaghan AD, Jaimes EA, Malyszko J, Perazella MA, Sprangers B, Rosner MH.
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):289-297. doi: 10.2215/CJN.08580719. Epub 2019 Dec 13.
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update.
Giraud EL, de Lijster B, Krens SD, Desar IME, Boerrigter E, van Erp NP.
Lancet Oncol. 2023 Jun;24(6):e229. doi: 10.1016/S1470-2045(23)00216-4.
Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats.
Matar KM, Tayem YI.
Biomed Res Int. 2014;2014:570910. doi: 10.1155/2014/570910. Epub 2014 Jun 9.
Impact of hepatic impairment and renal failure on the pharmacokinetics of linezolid and its metabolites: contribution of hepatic metabolism and renal excretion.
Liu J, Pang Y, Li W, Sun J, He Y, Guo Y, Dong J.
Antimicrob Agents Chemother. 2025 May 7;69(5):e0189224. doi: 10.1128/aac.01892-24. Epub 2025 Apr 14.
Acute Liver Failure.
Rajaram P, Subramanian R.
Semin Respir Crit Care Med. 2018 Oct;39(5):513-522. doi: 10.1055/s-0038-1673372. Epub 2018 Nov 28.
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies.
Pennisi G, Infantino G, Celsa C, Di Maria G, Enea M, Vaccaro M, Cannella R, Ciccioli C, La Mantia C, Mantovani A, Mercurio F, Tilg H, Targher G, Di Marco V, Cammà C, Petta S.
Liver Int. 2024 Nov;44(11):2939-2949. doi: 10.1111/liv.16075. Epub 2024 Aug 19.
Asterixis.
Ellul MA, Cross TJ, Larner AJ.
Pract Neurol. 2017 Jan;17(1):60-62. doi: 10.1136/practneurol-2016-001393. Epub 2016 Nov 2.
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG.
Hepatol Int. 2018 Feb;12(Suppl 1):34-43. doi: 10.1007/s12072-017-9808-z. Epub 2017 Jul 5.
Bioartificial organ support for hepatic, renal, and hematologic failure.
Maguire PJ, Stevens C, Humes HD, Shander A, Halpern NA, Pastores SM.
Crit Care Clin. 2000 Oct;16(4):681-94. doi: 10.1016/s0749-0704(05)70140-8.
